Novacyt Stock

Novacyt Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Novacyt (ALNOV.PA) as of Sep 16, 2026 is 23.52 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 89.94 % — a change of -73.85% (lower).

Cash Conversion

23.52 %

YoY

-73.85%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Novacyt is 2026 23.52 % . Cash Conversion Rate (OCF/Net Income) of Novacyt was 2025 89.94 % . It decreases by -73.85% lower compared to the previous year.

The Novacyt Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2017
85.37 GBP
Jan 1, 2018
26.32 GBP
Jan 1, 2019
16.37 GBP
Jan 1, 2020
77.76 GBP
Jan 1, 2021
-161.28 GBP
Jan 1, 2022
53.36 GBP
Jan 1, 2023
89.94 GBP
Jan 1, 2024
23.52 GBP
The Novacyt Cash Conversion history
YEARCash ConversionYoY
23.52 %-73.85%
89.94 %+68.56%
53.36 %-133.08%
-161.28 %-307.40%
77.76 %+375.09%
16.37 %-37.81%
26.32 %-69.17%
85.37 %+90.46%
44.83 %+16.62%
38.44 %-28.43%
53.71 %
Access this data via the Eulerpool API

Novacyt Stock analysis

What does Novacyt do? Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. The company was founded in 2006 and has experienced impressive growth since then. Its headquarters are located in Paris. Novacyt's business model revolves around the development and marketing of diagnostic products and technologies, particularly molecular diagnostic kits and reagents used for identification and quantification of microorganisms, viruses, and genetic differences. These products are commonly used in medical research, clinical diagnostics, and environmental analysis. Novacyt is divided into several divisions, each offering different products and services. Its diagnostic business specializes in the research, development, and marketing of molecular diagnostic kits, including the Primerdesign Kits specifically designed for COVID-19 identification. The company also provides laboratory and service offerings, such as DNA sequencing, qPCR analysis, sample preparation, and PCR disinfection. Additionally, Novacyt offers various diagnostic tests capable of detecting genetic differences and mutations. Its PathFlow division focuses on improving the process from diagnosis to therapy and follow-up, particularly for oncology patients. In response to the COVID-19 pandemic, Novacyt quickly launched a PCR test kit for COVID-19, which has been approved in numerous countries worldwide. Novacyt has successfully established itself as a key player in the fight against the pandemic. In summary, Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. Through its divisions, the company ensures the optimal utilization of molecular diagnostic tests. Novacyt has become an important player in the fight against the pandemic through its rapid response and development of molecular diagnostic kits for COVID-19, establishing itself as a reliable and innovative partner for medical research and clinical diagnostics. Novacyt is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novacyt stock

Cash Conversion Rate (OCF/Net Income) of Novacyt is 23.52 % in 2026.

Cash Conversion Rate (OCF/Net Income) of Novacyt changed from 89.94 % to 23.52 %, representing a -73.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Novacyt since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Novacyt with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

Cash Flow — Novacyt

All Key Metrics — Novacyt